TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI)

CUSIP: 89680M101

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
+9,339,944
SEC-reported price per share
$4.00
Number of holders
84
Value change
+$33,695,127
Number of buys
50
Number of sells
23
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
61,417,523

Security key

89680M101

Report period

Q1 2026

Institutions

84

Top holders

10

Ownership snapshot

Top reported holders of TLSI - TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Frankenius Equity AB
Disclosed value leader
Frankenius Equity AB
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 3/4/5 13F Lead comparable stake: 14% 13D/G row: Frankenius Equity AB Showing 1-6 of 15 holder rows.

Quick read

Frankenius Equity AB leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Frankenius Equity AB's linked filing trail.
Comparable ownership Top 5
Frankenius Equity AB 14%
Mats Wahlstrom 6%
Utmost Group Plc 5.7%
Nantahala Capital Management, LLC 4.1%
BlackRock, Inc. 2.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Frankenius Equity AB
13D/G 3/4/5
10%+ Owner
14%
$34,179,868
6,989,748 shares
+$1,257,864 31 Jul 2025
Mats Wahlstrom
13D/G
6%
$14,610,738
2,987,881 shares
+$931,271 31 Jul 2025
Utmost Group Plc
13D/G
5.7%
$14,644,149
3,503,385 shares
+$493,867 31 Mar 2026
Nantahala Capital Management, LLC
13F 13D/G
Company
4.1%
from 13D/G
$14,454,372
2,070,827 shares
31 Dec 2025
BlackRock, Inc.
13F
Company
13F
2.5%
$10,709,665
1,534,336 shares
31 Dec 2025
VANGUARD GROUP INC
13F
Company
13F
2.5%
$10,684,335
1,530,707 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
84
Shares
20,817,522
Rows available
84
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
63
Q1 2026 holders
84
Holder diff
21
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .